Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 7549026 | HLA-DQB1 (HLA-DQB1) | gastrointestinal diseases | NA | NA | NA | negation | |
| gliadin antibodies are also found in other gastrointestinal diseases, other disorders and in healthy individuals not carrying the coeliac disease-specific dqa/dqb alleles. | |||||||
| 7549031 | HLA-DQB1*02 | vitamin | NA | hepatitis | NA | unclassified | |
| NA | |||||||
| 7549031 | HLA-DR (HLA-DR) | vitamin | NA | hepatitis | NA | unclassified | |
| NA | |||||||
| 7549031 | HLA-DQA1*05 | vitamin | NA | hepatitis | NA | unclassified | |
| NA | |||||||
| 7558928 | HLA-DR (HLA-DR) | polytrauma | NA | NA | NA | unclassified | |
| expression of hla-dr in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. | |||||||
| 9787955 | HLA (HLA) | thrombosis | NA | NA | NA | positive+negation | |
| in contrast, no association was discerned between post-transplant thrombosis and prior sensitization to hla : our data demonstrates that patients with apas are at high risk for development of post-transplant renal thrombosis. | |||||||
| 10528648 | HLA (HLA) | thrombosis | NA | NA | NA | unclassified | |
| in the future, just as we now expand the specificity of hla gene typing with molecular biology, genotyping for recognized thrombophilia genes in patients at risk will expand our ability to recognize and prevent thrombosis with targeted interventions drawn from the increasing array of anticoagulants now available. | |||||||
| 10528648 | HLA (HLA) | thrombophilia | NA | NA | NA | unclassified | |
| in the future, just as we now expand the specificity of hla gene typing with molecular biology, genotyping for recognized thrombophilia genes in patients at risk will expand our ability to recognize and prevent thrombosis with targeted interventions drawn from the increasing array of anticoagulants now available. | |||||||
| 18455039 | HLA (HLA) | thrombosis | NA | hepatitis | NA | unclassified | |
| in this case, the histological exam was compatible with hyperacute rejection, excluding the diagnoses of hepatic artery thrombosis or biliary obstruction, despite the negative test for anti-hla antibodies. | |||||||
| 20505494 | HLA-DR (HLA-DR) | thrombosis | NA | glucose | NA | positive+negation | |
| in this cohort, cvd risk was related to traditional cvd risk factors and markers of thrombosis and endothelial damage, but not to high-sensitivity c-reactive protein or markers of t-cell activation such as cd38/human leukocyte antigen-dr coexpression. | |||||||
Copyright 2024